Search hospitals > Illinois > Aurora
Rush - Copley Medical Center
Claim this profileAurora, Illinois 60504
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
305 reported clinical trials
13 medical researchers
Summary
Rush - Copley Medical Center is a medical facility located in Aurora, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Rush - Copley Medical Center is involved with conducting 305 clinical trials across 456 conditions. There are 13 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Kendrith Rowland, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Vamsi K. VasireddyCarle Cancer Center2 years of reported clinical research
Expert in Cancer
Studies Tumors
31 reported clinical trials
56 drugs studied
Maria T. Grosse-PerdekampCarle Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
29 reported clinical trials
60 drugs studied
Suparna ManthaCarle Cancer Center4 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
32 reported clinical trials
67 drugs studied
Kendrith Rowland, MDCarle Cancer Center2 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
61 drugs studied
Clinical Trials running at Rush - Copley Medical Center
Breast Cancer
Lung Cancer
Prostate Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Gastric Cancer
Tumors
Rectal Cancer
Esophageal Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rush - Copley Medical Center?
Rush - Copley Medical Center is a medical facility located in Aurora, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Rush - Copley Medical Center is involved with conducting 305 clinical trials across 456 conditions. There are 13 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Kendrith Rowland, MD.